- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/145 - Orthomyxoviridae, e.g. influenza virus
Patent holdings for IPC class A61K 39/145
Total number of patents in this class: 2859
10-year publication summary
|
189
|
190
|
168
|
196
|
180
|
156
|
163
|
178
|
214
|
102
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1653 |
79 |
| Seqirus UK Limited | 429 |
58 |
| Icahn School of Medicine at Mount Sinai | 955 |
47 |
| Curevac SE | 264 |
43 |
| Wisconsin Alumni Research Foundation | 3889 |
42 |
| University of Georgia Research Foundation, Inc. | 1033 |
39 |
| Sanofi Pasteur Inc. | 363 |
36 |
| Janssen Vaccines & Prevention B.V. | 310 |
32 |
| Modernatx, Inc. | 1259 |
31 |
| Novartis AG | 10741 |
30 |
| The Trustees of the University of Pennsylvania | 4326 |
30 |
| Aramis Biotechnologies Inc. | 56 |
28 |
| FluGen, Inc. | 36 |
26 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2858 |
25 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3171 |
24 |
| Academia Sinica | 943 |
23 |
| Intervet Inc. | 910 |
22 |
| University of Rochester | 1304 |
22 |
| Novavax, Inc. | 164 |
21 |
| Zoetis Services LLC | 1535 |
21 |
| Other owners | 2180 |